首页> 美国卫生研究院文献>Frontiers in Psychiatry >Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation in Adolescents with Major Depressive Disorder
【2h】

Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation in Adolescents with Major Depressive Disorder

机译:反复经颅磁刺激对重度抑郁症青少年的神经认知作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

>Objectives: It is estimated that 30–40% of adolescents with major depressive disorder (MDD) do not receive full benefit from current antidepressant therapies. Repetitive transcranial magnetic stimulation (rTMS) is a novel therapy approved by the US Food and Drug Administration to treat adults with MDD. Research suggests rTMS is not associated with adverse neurocognitive effects in adult populations; however, there is no documentation of its neurocognitive effects in adolescents. This is a secondary post hoc analysis of neurocognitive outcome in adolescents who were treated with open-label rTMS in two separate studies.>Methods: Eighteen patients (mean age, 16.2 ± 1.1 years; 11 females, 7 males) with MDD who failed to adequately respond to at least one antidepressant agent were enrolled in the study. Fourteen patients completed all 30 rTMS treatments (5 days/week, 120% of motor threshold, 10 Hz, 3,000 stimulations per session) applied to the left dorsolateral prefrontal cortex. Depression was rated using the Children’s Depression Rating Scale-Revised. Neurocognitive evaluation was performed at baseline and after completion of 30 rTMS treatments with the Children’s Auditory Verbal Learning Test (CAVLT) and Delis–Kaplan Executive Function System Trail Making Test.>Results: Over the course of 30 rTMS treatments, adolescents showed a substantial decrease in depression severity. Commensurate with improvement in depressive symptoms was a statistically significant improvement in memory and delayed verbal recall. Other learning and memory indices and executive function remained intact. Neither participants nor their family members reported clinically meaningful changes in neurocognitive function.>Conclusion: These preliminary findings suggest rTMS does not adversely impact neurocognitive functioning in adolescents and may provide subtle enhancement of verbal memory as measured by the CAVLT. Further controlled investigations with larger sample sizes and rigorous trial designs are warranted to confirm and extend these findings.
机译:>目标:据估计,患有重度抑郁症(MDD)的青少年中,有30%至40%不能从当前的抗抑郁疗法中获得全部收益。重复经颅磁刺激(rTMS)是一种获得美国食品和药物管理局批准的新型疗法,用于治疗患有MDD的成年人。研究表明,rTMS与成人人群的不良神经认知作用无关。但是,尚无有关其在青少年中的神经认知作用的文献。这是一项在两项单独的研究中对接受开放标签rTMS治疗的青少年的神经认知结局的事后分析。>方法::18例患者(平均年龄,16.2±1.1岁); 11例女性,7例男性)对未能对至少一种抗抑郁药产生充分反应的MDD进行了研究。 14名患者完成了全部30个rTMS治疗(5 d天/周,运动阈值的120%,10 Hz,每次疗程3,000次刺激),并治疗了左前外侧前额叶皮层。使用修订后的《儿童抑郁评分量表》对抑郁进行评分。在儿童的听觉语言学习测验(CAVLT)和Delis–Kaplan执行功能系统追踪制作测验的基线,以及完成30种rTMS治疗后,进行神经认知评估。>结果:在30种rTMS治疗过程中,青少年的抑郁症严重程度明显降低。与抑郁症状的改善相称的是记忆力和延迟言语回忆的统计学显着改善。其他学习记忆指标和执行功能保持不变。参与者及其家人均未报告神经认知功能在临床上有意义的变化。>结论:这些初步发现表明,rTMS不会对青少年的神经认知功能产生不利影响,并且可能会通过CAVLT测算出语言记忆的微妙增强。必须进行更大样本量和严格试验设计的进一步对照研究,以确认和扩展这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号